Centessa Pharmaceuticals Valuation
| CNTA Stock | USD 17.60 0.30 1.73% |
At this time, the firm appears to be overvalued. Centessa Pharmaceuticals shows a prevailing Real Value of $14.1 per share. The current price of the firm is $17.6. Our model approximates the value of Centessa Pharmaceuticals from analyzing the firm fundamentals such as Operating Margin of (23.59) %, return on equity of -0.43, and Shares Outstanding of 131.84 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Centessa Pharmaceuticals' valuation include:
Price Book 4.649 | Enterprise Value 1.9 B | Enterprise Value Ebitda 1.1183 | Price Sales 338.6068 | Enterprise Value Revenue 275.3176 |
Overvalued
Today
Please note that Centessa Pharmaceuticals' price fluctuation is somewhat reliable at this time. Calculation of the real value of Centessa Pharmaceuticals is based on 3 months time horizon. Increasing Centessa Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Centessa Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Centessa Stock. However, Centessa Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 17.6 | Real 14.1 | Target 8.8 | Hype 17.6 | Naive 17.35 |
The real value of Centessa Stock, also known as its intrinsic value, is the underlying worth of Centessa Pharmaceuticals Company, which is reflected in its stock price. It is based on Centessa Pharmaceuticals' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Centessa Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Centessa Pharmaceuticals PLC helps investors to forecast how Centessa stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Centessa Pharmaceuticals more accurately as focusing exclusively on Centessa Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Centessa Pharmaceuticals' intrinsic value based on its ongoing forecasts of Centessa Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Centessa Pharmaceuticals' closest peers. If more than one evaluation category is relevant for Centessa Pharmaceuticals we suggest using both methods to arrive at a better estimate.
Centessa Pharmaceuticals Cash |
|
Centessa Valuation Trend
Comparing Centessa Pharmaceuticals' enterprise value against its market capitalization is a good way to estimate the value of Centessa Pharmaceuticals PLC uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Centessa Pharmaceuticals Total Value Analysis
Centessa Pharmaceuticals PLC is currently anticipated to have valuation of 1.89 B with market capitalization of 2.32 B, debt of 84.59 M, and cash on hands of 484.16 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Centessa Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.89 B | 2.32 B | 84.59 M | 484.16 M |
Centessa Pharmaceuticals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Centessa Pharmaceuticals has an asset utilization ratio of 1.9 percent. This suggests that the Company is making $0.019 for each dollar of assets. An increasing asset utilization means that Centessa Pharmaceuticals PLC is more efficient with each dollar of assets it utilizes for everyday operations.Centessa Pharmaceuticals Ownership Allocation
Centessa Pharmaceuticals holds a total of 131.84 Million outstanding shares. The majority of Centessa Pharmaceuticals PLC outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Centessa Pharmaceuticals to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Centessa Pharmaceuticals. Please pay attention to any change in the institutional holdings of Centessa Pharmaceuticals PLC as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Centessa Pharmaceuticals Profitability Analysis
The company reported the previous year's revenue of 6.85 M. Net Loss for the year was (151.09 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Centessa Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Centessa Pharmaceuticals and how it compares across the competition.
About Centessa Pharmaceuticals Valuation
The stock valuation mechanism determines Centessa Pharmaceuticals' current worth on a weekly basis. Our valuation model uses a comparative analysis of Centessa Pharmaceuticals. We calculate exposure to Centessa Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Centessa Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 6.9 M | 7.2 M | |
| Pretax Profit Margin | (23.13) | (24.29) | |
| Operating Profit Margin | (22.49) | (23.62) | |
| Net Loss | (19.84) | (20.83) |
Centessa Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 96.2 M |
Centessa Pharmaceuticals Current Valuation Indicators
Valuation refers to the process of determining the present value of Centessa Pharmaceuticals PLC and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Centessa we look at many different elements of the entity such as Centessa's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Centessa Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Centessa Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Centessa Pharmaceuticals' worth.Complementary Tools for Centessa Stock analysis
When running Centessa Pharmaceuticals' price analysis, check to measure Centessa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Centessa Pharmaceuticals is operating at the current time. Most of Centessa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Centessa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Centessa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Centessa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |